Zomedica Corp. (ZOM) Social Stream



Zomedica Corp. (ZOM): $0.17

0.00 (-0.54%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

F

ZOMEDICA CORP (ZOM) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ZOMEDICA CORP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2023-03-16 1 $6 $6 $6 $0.168 3471.43%
2023-09-06 1 $0.44 $0.44 $0.44 $0.168 161.9%
NA 1 $NA $NA $NA $0.168 NA%

Price Target Last Issued September 6, 2023

The Trend in the Analyst Price Target


Over the past 35 weeks, ZOM's average price target has gone down $5.56.

Over the past 35 weeks, ZOM's average upside potential has been 1,065.66%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-09 1 6.00 6.00 6.00 0.280 2042.86%
2023-03-16 1 6.00 6.00 6.00 0.233 2475.11%
2023-05-15 1 0.44 0.44 0.44 0.209 110.53%
2023-08-11 1 0.44 0.44 0.44 0.200 120%
2023-09-06 1 0.44 0.44 0.44 0.183 140.44%

ZOM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 123 days, ZOM's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ZOM as an investment opportunity.

  • ZOMEDICA CORP's number of analysts covering the stock is higher than nearly none of all US stocks.
  • In terms of how ZOMEDICA CORP fares relative to all US stocks, note that its variance in analysts' estimates is lower than just about 100% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, ZOMEDICA CORP's average analyst price target is higher than 9.21% of them.
  • In terms of how ZOMEDICA CORP fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 158.02% of that group.

Stocks similar to ZOMEDICA CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SCPH, OPTN, and SPRO.

Is ZOM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!